Is NCT07810504 recruiting in Pasadena, CA?

Yes, NCT07810504 is currently recruiting participants at its Pasadena, CA location. This androgenic alopecia clinical trial is actively enrolling qualified participants.

How do I join the androgenic alopecia clinical trial in Pasadena?

To join this clinical trial in Pasadena, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Pasadena clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Androgenic Alopecia Clinical Trial in Pasadena, CA

About This Androgenic Alopecia Study in Pasadena

This single-center, prospective, randomized, placebo-controlled interventional study will evaluate the safety and efficacy of KeraFactor scalp-stimulating solution and the Revian Red wireless smart cap, alone and in combination, for the treatment of female androgenic alopecia. Forty female subjects aged 35 to 55 with clinically diagnosed androgenic alopecia will be randomized into four treatment arms and followed for 24 weeks. The primary objective is to determine whether combination therapy produces greater improvement in hair growth from baseline to 6 months compared with solution alone, device alone, or placebo. Secondary outcomes include changes in hair density, hair fiber diameter, interfollicular distance, terminal-to-vellus hair ratio, patient satisfaction, and safety/tolerability.

Sponsor: K. Kay Durairaj, MD, FACS, A Medical Corporation

Who Can Participate

Inclusion Criteria

Female participants aged 35 to 55 years, inclusive.

Clinically diagnosed with androgenic alopecia.

Fitzpatrick Skin Types I-VI.

Willingness to undergo baseline laboratory screening, including CBC, TSH, iron/TIBC, 25-hydroxyvitamin D, ferritin, free testosterone, total testosterone, estradiol (E2), and FSH, to confirm eligibility and stratification status.

Generally healthy individuals with no significant dermatological conditions affecting the scalp, such as eczema, psoriasis, or folliculitis, that could interfere with treatment assessment.

Willingness to maintain a consistent hair care routine and refrain from new hair treatments, supplements, or grooming practices that could confound study results.

Willingness and ability to provide recent laboratory results to establish baseline metabolic parameters.

Participants must have a smartphone or tablet that operates on iOS version 11.0 or higher and/or Android 9.0 or higher, access to the Apple App Store or Google Play to download the REVIAN app, and internet or wireless network connectivity.

Commitment to avoid hair dryer use for at least 48 hours before and after each office visit.

Commitment to avoid hair extensions for at least 6 months prior to and throughout the study duration.

Ability and willingness to adhere to the study protocol, including scheduled visits and assessments.

Willingness to allow trichoscopic and photographic documentation of the scalp and hair.

Ability and willingness to provide written informed consent after being fully informed about the study's nature, purpose, procedures, potential risks, and benefits.

Exclusion Criteria

Presence of autoimmune or pathologic causes of hair loss, such as alopecia areata or lichen planus.

Active scalp disorders or infections, such as eczema, psoriasis, seborrheic dermatitis, or folliculitis.

Clinically significant abnormalities in baseline screening labs, including CBC, TSH, iron/TIBC, 25-hydroxyvitamin D, ferritin, free testosterone, total testosterone, E2, and FSH, that fall outside satisfactory ranges for hair growth or indicate an underlying medical pathology, such as iron deficiency anemia or thyroid dysfunction.

History of hypersensitivity to any components of KeraFactor scalp-stimulating solution.

Presence of a medical condition that makes the skin sensitive to sun or light, or use of photosensitizing medications, shampoos, lotions, or other therapies that sensitize the skin to light.

Medical conditions or medications known to significantly affect hair growth, including uncontrolled thyroid disorders, anemia, cancer, chemotherapy, spironolactone, 5-alpha-reductase inhibitors, or cyproterone.

Active use of GLP-1 receptor agonists, such as Ozempic, Wegovy, Mounjaro, Zepbound, or similar medications.

Active use of topical treatments for hair regrowth, such as minoxidil or finasteride.

Pregnant, breastfeeding, or planning to become pregnant during the study.

Unrealistic expectations or psychological conditions that may impact study compliance or satisfaction.

Continual use of red-light or low-level laser therapy outside of study requirements.

Recent initiation of topical hair regrowth treatments, such as minoxidil or finasteride.

Continual use of minoxidil, finasteride, or other hair regrowth treatments.

Any active cancer or cancer diagnosis.

Active smoking habit.

History of hair transplant procedures.

Significant scalp scarring or structural anomalies in treatment zones.

Recent major surgeries or medical interventions within the last 3 months.

History of prolonged or repeated mechanical tension on the hair or scalp, such as tight hairstyles contributing to traction alopecia.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pasadena?

Yes, this clinical trial (NCT07810504) has an active research site in Pasadena, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Androgenic Alopecia Treatment Options in Pasadena, CA

If you're searching for androgenic alopecia treatment options in Pasadena, CA, this clinical trial (NCT07810504) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pasadena research site is actively enrolling participants for this clinical trial. You'll receive care from experienced androgenic alopecia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all androgenic alopecia clinical trials near you to find additional studies recruiting in your area.

Androgenic Alopecia Clinical Trial in Pasadena, CA

Expert Care in Pasadena

IRB Approved

No-Cost Care

Apply for This Pasadena Location

Why Participate?

Simple Process